Characteristics of participants on antihypertensive medications with versus without left ventricular hypertrophy (LVH) on echocardiogram (n=56)
| Characteristic | No LVH on echocardiogram n=38 | LVH on echocardiogram n=18 | *P value |
| Median age (IQR) | 50.5 (42–57) | 54.5 (51–66) | 0.02 |
| Female, n (%) | 28 (73.7) | 7 (38.9) | 0.01 |
| Median BMI (IQR)† | 24.0 (22.0–27.7) | 27.6 (22.5–30.4) | 0.30 |
| Median duration on ART (IQR) | 7.3 (5.0–9.8) | 8.1 (6.1–11.4) | 0.25 |
| Mean systolic blood pressure, mm Hg (SD) | 156 (19.4) | 174 (20.4) | 0.002 |
| Mean diastolic blood pressure, mm Hg (SD) | 93 (11.3) | 96 (15.7) | 0.47 |
| Blood pressure <140/90 mm Hg, n (%) | 5 (13.2) | 0 (0.0) | 0.09 |
| Blood pressure 140–159 and/or 90–99 mm Hg, n (%) | 16 (42.1) | 5 (27.8) | |
| Blood pressure ≥160 and/or ≥100 mm Hg, n (%) | 17 (44.7) | 13 (72.2) |
*P values determined by χ2 and t-tests or rank-sum tests.
†BMI missing for one participant with LVH.
ART, antiretroviral therapy; BMI, body mass index.